CluePoints furthers its commitment to
delivering innovative solutions that enhance clinical trial
efficiency with this latest addition to its enterprise software
platform.
KING OF
PRUSSIA, Pa., Sept. 27,
2024 /PRNewswire/ -- CluePoints continues to
transform clinical trial review and leverage its industry-leading
software to enhance the interrogation, analysis and presentation of
data with the launch of its latest application, Medical &
Safety Review (MSR).
The tool simplifies and streamlines the medical analysis of
study data through user-friendly dashboards, data manipulation and
cleaning, query management and full transparency over the data
history. This not only improves efficiency and communication in
medical oversight, but also elevates patient safety,
differentiating MSR as a smarter and unique solution.
Designed by, and for Medical and Safety Reviewers, MSR converts
the manual analysis of patient outcomes, which can be prone to
inefficiency and error, into an accurate, efficient process. MSR
tackles time-consuming study preparation for specific
visualizations by featuring a comprehensive standard visualization
library as well as the ability to copy and reuse dashboards across
different studies, enabling the identification of outlying values,
change tracking, and improved communication for smarter clinical
trials.
Other benefits of MSR include:
- Enhanced medical review efficiency and reduced human errors via
automated checks
- Reduced time spent by clinical and data management teams in
reviewing data
- Improved collaboration with integrated review workflows across
departments
- Ensured record quality and accountability with comprehensive
change tracking
- Driving faster decision making with the proactive detection of
trends and safety issues
- Ensuring regulatory compliance with rule-based detection and
user assignments
Andy Cooper, Chief
Executive Officer at CluePoints, commented, "We are
thrilled to announce the launch of Medical & Safety Review to
our growing product offerings. MSR is the latest application
addition to the CluePoints platform, which includes products such
as Risk-Based Quality Management (RBQM) and our Site Profile &
Oversight Tool (SPOT). Together, they provide a comprehensive
approach to clinical trial optimization, enhancing data integrity,
ensuring regulatory compliance, and accelerating drug development.
The creation of MSR ensures a more streamlined review process while
prioritizing patient safety at every step and empowers medical
teams to swiftly identify outliers, track data changes, and improve
communication."
To learn more about CluePoints' award-winning solutions, please
visit www.cluepoints.com
About CluePoints
CluePoints is the premier Risk-Based Quality
Management (RBQM) and Data Quality Oversight Software
provider. We are leveraging the potential of Artificial
Intelligence using Advanced Statistics and Machine Learning to
determine the quality, accuracy, and integrity of clinical
trial data both during and after study conduct. Aligned with
guidance from the FDA, EMA, and ICH E6 (R2), CluePoints is
deployed to support central and on-site monitoring, medical
review, quality risk management and to drive a holistic
Risk-Based strategy in all trials. Coupled with thought
leadership and consulting expertise to aid pre-study risk
assessment, identification of risk controls and
solution implementation, you now have everything you need to
adhere with global regulatory guidance. The result is positive
clinical development outcomes, increased operational
efficiency, lower costs and reduced regulatory submission risk
as part of the industry paradigm shift to RBQM.
View original
content:https://www.prnewswire.com/news-releases/cluepoints-launches-medical--safety-review-msr-software-to-revolutionize-clinical-data-review-302260932.html
SOURCE CluePoints